Use of platelet and erythroid growth factors during induction chemotherapy for acute lymphoblastic leukaemia in a Jehovah’s Witness

We present a 21-year-old woman diagnosed with Philadelphia (Ph) chromosome-like CD20 positive B-cell acute lymphoblastic leukaemia (ALL). She was a Jehovah’s Witness (JW) and declined all blood product transfusion support. She was initiated on the CALGB 10403 chemotherapy protocol for her ALL. She r...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:BMJ Case Rep
Egile Nagusiak: Arora, Nivedita, Gupta, Arjun, Li, Hsiao C, Sadeghi, Navid
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BMJ Publishing Group 2018
Gaiak:
Novel Treatment (New Drug/Intervention; Established Drug/Procedure in New Situation)
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6301473/
https://ncbi.nlm.nih.gov/pubmed/30567199
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2018-226497
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak